News

The company is focused on using its Verisome drug-delivery platform in the development of new unique intraocular eye-care therapeutics. IBI-10090, which employs the Verisome technology, has been designed

This recall is a precautionary measure based on the company’s investigation of visible particulate matter found in a small number of COUMADIN FOR INJECTION unreleased samples. Bristol-Myers Squibb

The product is marketed under the brand name ‘Breo Ellipta’ and is indicated for asthma patients aged 12 years and older. The sNDA is for approval of two

During this collaboration, a focused research team at Roche will work with Stratos scientists to support the development of efficient, low-cost sample preparation methods for DNA Xpandomers and

Developed by Eli Lilly and Boehringer Ingelheim, the new insulin glargine product is the first biosimilar insulin recommended for approval in the European Union (EU). The new insulin

The inhalation powder in AFREZZA is delivered using a small, discreet and easy-to-use inhaler. The company said that the AFREZZA should be administered at the start of a

According to the company, the CHMP positive opinion of Triumeq (dolutegravir/abacavir/lamivudine) is based upon data from two major studies. The first study is a Phase III trial of

The single-center, randomized withdrawal trial will enrol about 12 PWS patients between 10 and 20 years old. During the trial, patients will be titrated through five doses of

The CHMP’s positive opinion will now be reviewed by the European Commission (EC). The decision on whether to approve Eliquis for this indication will be made by the